State-of-the-art in the Management of Cancer Meeting Coverage Cancers of the Digestive System-part Ii

CANCERS OF THE DIGESTIVE SYSTEM-PART II SCREENING, DIAGNOSIS, AND MONITORING 34 Esophageal Cancer 34 Stomach Cancer 34 Liver Cancer 35 Pancreatic Cancer 36 Colorectal Cancer 37 Occult blood 37 Flexible sigmoidoscopy 37 Tumor markers 38 Genetic testing 38 Screening of high risk groups 38 Radioimmunoscintigraphy 39 Gallbladder Cancer 39 Cancer of the Small Intestine 39 Anal Cancer 40 CURRENT THERAPY 40 Esophageal Cancer 40 Stomach Cancer 41 Primary Hepatocellular Carcinoma (HCC) 41 Metastatic Neoplasms of the Liver 42 Regional therapy 43 Chemoembolization 44 Radiotherapy 44 Liver transplants 45 Other therapies 45 Neoplasms of the Extrahepatic Bile Ducts 45 Pancreatic Cancer 46 Colorectal Cancer 47 Gallbladder Cancer 49 Cancer of the Small Intestine 49 Anal Cancer 50 NEW DRUGS AND ALLIED THERAPIES IN DEVELOPMENT 50 Gene Therapy/Vaccines /Immunomodulating Agents/Monoclonal Antibodies 51 Aphton 51 Biomira 51 Bristol-Myers Squibb 51 Canji 51 Centocor 52 Corixa 52 Cytel 52 Genetics Institute 52 ImClone 52 Immune Response 53 Immunomedics 53 ImmunoTherapeutics 53 Jenner Technologies 53 NeoRx 53 Seragen 53 Somatix Therapy 53 StressGen Biotechnologies 53 Therion Biologics 54 University of Alabama 54 Vical 54 The Wistar Institute 54 Thymidylate Synthase Inhibitors 54 ZD1694 55 AG337 and AG331 55 UFT 55 Topoisomerase I Inhibitors 56 CPT-11 56 Drug Delivery 56 Liposomes 56 Matrix Pharmaceutical 56 Sparta Pharmaceuticals 56 Photodynamic Therapy (PDT) 56